$251 Million is the total value of KNOTT DAVID M's 143 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 31.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PFE | Sell | Pfizer Inc. | $6,158,000 | -61.2% | 145,000 | -60.1% | 2.46% | -67.1% |
| MIK | Sell | The Michaels Companies, Inc. | $3,426,000 | -41.2% | 300,000 | -30.2% | 1.37% | -50.1% |
| IRDM | Sell | Iridium Communications, Inc. | $2,998,000 | -42.3% | 113,399 | -59.7% | 1.20% | -51.1% |
| CPRX | Sell | Catalyst Pharmaceuticals, Inc. | $2,605,000 | +121.1% | 510,847 | -16.7% | 1.04% | +87.4% |
| VKTX | Sell | Viking Therapeutics, Inc. | $2,168,000 | +19.1% | 218,102 | -8.4% | 0.86% | +0.9% |
| BDSI | Sell | BioDelivery Sciences International, Inc. | $2,123,000 | +14.7% | 400,500 | -19.9% | 0.85% | -2.8% |
| ARNA | Sell | Arena Pharmaceuticals, Inc. | $1,644,000 | +6.0% | 36,676 | -7.9% | 0.66% | -10.2% |
| HZNP | Sell | Horizon Pharma Public Limited Company | $1,264,000 | -12.2% | 47,840 | -35.0% | 0.50% | -25.4% |
| WHLRD | Sell | Wheeler Real Estate Investment Trust, Inc. | $201,000 | +25.6% | 14,309 | -14.0% | 0.08% | +6.7% |
| VIVE | Sell | Viveve Medical, Inc. | $41,000 | -38.8% | 43,649 | -31.2% | 0.02% | -48.4% |
| OZM | Sell | Och-Ziff Capital Management Group | $3,000 | +50.0% | 200 | -90.0% | 0.00% | 0.0% |
| Exit | Peoples United Financial | $0 | – | -1,500 | -100.0% | -0.01% | – | |
| Exit | Novartis AG | $0 | – | -3,000 | -100.0% | -0.12% | – | |
| KPTI | Exit | Karyopharm Therapeutics, Inc. | $0 | – | -36,000 | -100.0% | -0.16% | – |
| JBSAY | Exit | JBS S.A. | $0 | – | -190,400 | -100.0% | -0.53% | – |
| NBL | Exit | Noble Energy, Inc. | $0 | – | -96,000 | -100.0% | -0.85% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 34 | Q3 2021 | 52.6% |
| Pfizer Inc. | 34 | Q3 2021 | 17.4% |
| Capitol Federal S&L | 34 | Q3 2021 | 5.7% |
| JP Morgan Chase& Co. | 34 | Q3 2021 | 1.3% |
| Apple Inc. | 34 | Q3 2021 | 2.1% |
| Microsoft Corporation | 34 | Q3 2021 | 2.3% |
| AllianceBernstein Holdings PL Unit Ltd. | 34 | Q3 2021 | 0.9% |
| Johnson & Johnson | 34 | Q3 2021 | 0.6% |
| Mondelez Int'lt Inc. | 34 | Q3 2021 | 0.5% |
| Ryman Hospitality PPTYS Inc. | 34 | Q3 2021 | 0.4% |
View KNOTT DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | February 13, 2018 | 865,500 | 4.1% |
| Rand Logistics, Inc. | November 15, 2017 | 1,432,660 | 7.2% |
| Essex Rental Corp. | August 16, 2013 | 1,124,472 | 4.5% |
| Westway Group, Inc. | February 01, 2013 | ? | ? |
| FutureFuel Corp. | February 01, 2012 | 1,838,000 | 4.5% |
| COLUMBIA LABORATORIES INC | January 31, 2012 | ? | ? |
| Essex Rental Corp. | February 16, 2011 | 2,805,666 | 13.0% |
| Pet DRx CORPSold out | February 09, 2011 | 0 | 0.0% |
| China Ceramics Co., Ltd | October 14, 2010 | 1,350,000 | 10.3% |
| NABI BIOPHARMACEUTICALS | June 22, 2010 | 2,344,597 | 4.8% |
View KNOTT DAVID M's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-13 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-12 |
| 13F-HR | 2019-08-12 |
View KNOTT DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.